ZUNXOLTRA Trademark

Trademark Overview

On Thursday, February 12, 2026, a trademark application was filed for ZUNXOLTRA with the United States Patent and Trademark Office. The USPTO has given the ZUNXOLTRA trademark a serial number of 99649939. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 19, 2026. This trademark is owned by Juno Therapeutics, Inc.. The ZUNXOLTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
zunxoltra

General Information

Serial Number99649939
Word MarkZUNXOLTRA
Filing DateThursday, February 12, 2026
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 19, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 12, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJuno Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
US
Party NameJuno Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
US

Trademark Events

Event DateEvent Description
Thursday, February 12, 2026NEW APPLICATION ENTERED
Thursday, February 12, 2026APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 20, 2026ASSIGNED TO EXAMINER
Tuesday, April 21, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 13, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 19, 2026PUBLISHED FOR OPPOSITION
Tuesday, May 19, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

zunxoltra diseases preparations purposes disease cancer medical treatment diagnostic solid radiopharmaceutical